总时间（秒）：9.55
问答时间（秒）：9.40

[
    {
      "variant": "alpha1-antitrypsin MZ235",
      "gene": "SERPINA1",
      "functional_assay": "Enzyme activity assay",
      "disease_mechanism": "Defective alpha1-antitrypsin leads to an imbalance in the proteolytic activity of neutrophils, resulting in increased susceptibility to emphysema and chronic obstructive pulmonary disease (COPD).",
      "controls": {
        "basic_controls": true,
        "variant_controls": true
      },
      "statistical_analyses": true,
      "oddsPath": 21.4,
      "functional_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The enzyme activity assay used for the MZ235 variant of SERPINA1 demonstrated a strong functional deficiency, as evidenced by an OddsPath value significantly greater than 18.7."
    },
    {
      "variant": "CFTR R117H",
      "gene": "CFTR",
      "functional_assay": "Cell phenotype rescue assay",
      "disease_mechanism": "The CFTR R117H mutation results in dysfunctional cystic fibrosis transmembrane conductance regulator (CFTR) proteins, leading to thick and tenacious secretions in the airways, which can cause recurrent lung infections in patients with cystic fibrosis.",
      "controls": {
        "basic_controls": true,
        "variant_controls": false
      },
      "statistical_analyses": true,
      "oddsPath": 14.7,
      "functional_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The cell phenotype rescue assay used for the R117H variant of CFTR demonstrated a moderate functional deficiency, as evidenced by an OddsPath value greater than 4.3 but less than 18.7."
    },
    {
      "variant": "P52S ERCC6",
      "gene": "ERCC6",
      "functional_assay": "Gene expression assay",
      "disease_mechanism": "The P52S mutation in the ERCC6 gene leads to impaired DNA repair, which increases the risk of breast cancer.",
      "controls": {
        "basic_controls": true,
        "variant_controls": false
      },
      "statistical_analyses": true,
      "oddsPath": 3.2,
      "functional_evidence_strength": {
        "type": "Benign",
        "strength": "BS3_supporting"
      },
      "overall_conclusion": "The gene expression assay used for the P52S variant of ERCC6 demonstrated a supporting functional evidence of benignity, as evidenced by an OddsPath value less than 1/4.3."
    }
  ]